Active Implantable Medical Device Manufacturers Assured of Seamless UKCA and CE Certification with TÜV SÜD’s Approved Body Designation Extension

21st December 2023

TÜV SÜD has secured an extension to designation as a UK Approved Body (UKAB) for active implantable medical devices. It is the first UKAB to achieve a designation scope for active implantable medical devices after progressing through the full initial designation application process.

UKABs carry out medical device conformity assessments under the UKCA scheme. The scheme allows manufacturers to market their products in the UK. TÜV SÜD’s UKAB designation will help ease market pressure, at a time when industry is concerned by the limited capacity to conduct UKCA medical device conformity assessments within specified government deadlines. TÜV SÜD’s UKAB accreditation also offers medical device manufacturers the chance to gain UKCA and CE certification simultaneously which can reduce costs and time to market across Europe for new products.

Monisha Phillips, Head of UK Medical and Health Services (MHS) Certification Body at TÜV SÜD, said: “Extending our designation scope to include active implantable medical devices mirrors TÜV SÜD Germany’s EU Notified Body scope and will allow our active implantable medical devices clients to benefit from our full support for EU and UK market access, so they can optimise efficiencies.”

TÜV SÜD is now a designated UKAB for Part III of the UK Medical Devices Regulations 2002 (SI 618, as amended) for Active Implantable Medical Devices. Full details of the scope of designation can be accessed here: https://www.gov.uk/government/publications/medical-devices-uk-approved-bodies